Neuexcell

An early stage gene therapy company focusing on neurodegenerative diseases.

Launch date

2016

Employees

Market cap

Enterprise valuation

State College Pennsylvania (HQ)

Date	Investors	Amount	Round
-	Foothill Ventures	N/A	-
Sep 2021	Innovation Angel Fund Cowin Venture Oriza Seed Capital YuanBio Venture Capital Tsingyuan Ventures	$10.0m	Early VC
May 2023*	Suzhou Industrial Park Science and Technology Innovation Fund Shanghai Zhangjiang Leading Qifan Venture Capital Jiangxi Jilinxinsheng Enterprise Management Fujian Haixi Pharmaceuticals Suzhou Suxin Junnuo Venture Capital Guangzhou Huiju Xinxing Equity Investment Guangdong Jike Achievement Transformation Venture Capital Fund Quanzhou Hongshi II Venture Capital	$15.0m	Early VC
Total Funding		€22.7m

Recent News about Neuexcell